CN102272134B
(zh)
|
2008-12-09 |
2013-10-16 |
吉里德科学公司 |
Toll样受体调节剂
|
US8338441B2
(en)
*
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
CN103209963A
(zh)
|
2010-07-02 |
2013-07-17 |
吉里德科学公司 |
作为hiv抗病毒化合物的2-喹啉基-乙酸衍生物
|
CN103140474A
(zh)
|
2010-07-02 |
2013-06-05 |
吉里德科学公司 |
治疗aids的萘-2-基乙酸衍生物
|
US8633200B2
(en)
|
2010-09-08 |
2014-01-21 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
TW201302760A
(zh)
*
|
2011-04-04 |
2013-01-16 |
Gilead Sciences Inc |
製備hiv整合酶抑制劑之方法
|
EP2508511A1
(en)
|
2011-04-07 |
2012-10-10 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
ES2742261T3
(es)
|
2011-04-15 |
2020-02-13 |
Hivih |
Inhibidores de la replicación viral, su proceso de preparación y sus usos terapéuticos
|
BR112013027096A2
(pt)
|
2011-04-21 |
2016-12-27 |
Gilead Sciences Inc |
compostos de benzotiazol e seu uso farmacêutico
|
JP6205354B2
(ja)
|
2011-07-06 |
2017-09-27 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hivの処置のための化合物
|
US8791108B2
(en)
|
2011-08-18 |
2014-07-29 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
CN102952069B
(zh)
*
|
2011-08-19 |
2014-12-17 |
中国科学技术大学 |
一种化合物及其制备方法和应用
|
AP2014007595A0
(en)
*
|
2011-09-30 |
2014-04-30 |
Kineta Inc |
Anti-viral compounds
|
WO2013062028A1
(ja)
|
2011-10-25 |
2013-05-02 |
塩野義製薬株式会社 |
Hiv複製阻害剤
|
EP2781519B1
(en)
*
|
2011-11-15 |
2019-10-30 |
ST Pharm Co., Ltd. |
Novel antiviral pyrrolopyridine derivative and a production method for same
|
US9376392B2
(en)
|
2012-01-04 |
2016-06-28 |
Gilead Sciences, Inc. |
2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
|
WO2013103738A1
(en)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
Napthalene acetic acid derivatives against hiv infection
|
US8629276B2
(en)
|
2012-02-15 |
2014-01-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
US9034882B2
(en)
|
2012-03-05 |
2015-05-19 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
US9006235B2
(en)
|
2012-03-06 |
2015-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
MD20140063A2
(ro)
|
2012-04-20 |
2014-12-31 |
Gilead Sciences, Inc. |
Derivaţi de acid benzotiazol-6-il acetic şi utilizarea acestora pentru tratarea unei infecţii HIV
|
US8906929B2
(en)
|
2012-08-16 |
2014-12-09 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
EP2716632A1
(en)
|
2012-10-05 |
2014-04-09 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
EP2716639A1
(en)
|
2012-10-05 |
2014-04-09 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
EP2719685A1
(en)
*
|
2012-10-11 |
2014-04-16 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
JP5860197B1
(ja)
|
2013-01-09 |
2016-02-16 |
ギリアード サイエンシーズ, インコーポレイテッド |
ウイルス感染症を処置するための治療用化合物
|
ES2614053T3
(es)
|
2013-01-09 |
2017-05-29 |
Gilead Sciences, Inc. |
Heteroarilos de 5 miembros y su uso como antivirales
|
TW201443037A
(zh)
|
2013-01-09 |
2014-11-16 |
Gilead Sciences Inc |
治療用化合物
|
TW201441197A
(zh)
*
|
2013-01-31 |
2014-11-01 |
Shionogi & Co |
Hiv複製抑制劑
|
TWI706945B
(zh)
|
2013-03-01 |
2020-10-11 |
美商基利科學股份有限公司 |
供治療反轉錄病毒科病毒感染之治療性化合物
|
CN105189511B
(zh)
|
2013-03-13 |
2017-05-24 |
百时美施贵宝公司 |
人免疫缺陷病毒复制的抑制剂
|
WO2014164428A1
(en)
|
2013-03-13 |
2014-10-09 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
EP2970273B1
(en)
|
2013-03-13 |
2017-03-01 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
US9540393B2
(en)
|
2013-03-14 |
2017-01-10 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
ES2623904T3
(es)
|
2013-03-14 |
2017-07-12 |
VIIV Healthcare UK (No.5) Limited |
Inhibidores de la replicación del virus de la inmunodeficiencia humana
|
EP2821082A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Method of producing an inactivated lentivirus, especially HIV, vaccine, kit and method of use
|
EP2821104A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
NO2865735T3
(ja)
|
2013-07-12 |
2018-07-21 |
|
|
DK3019503T3
(da)
|
2013-07-12 |
2017-11-20 |
Gilead Sciences Inc |
Polycykliske-carbamoylpyridon-forbindelser og anvendelse deraf til behandling af hiv-infektioner
|
WO2015035217A1
(en)
|
2013-09-05 |
2015-03-12 |
Dow Agrosciences Llc |
Methods for producing borylated arenes
|
PT3105236T
(pt)
|
2014-02-12 |
2017-12-22 |
Viiv Healthcare Uk (No 5) Ltd |
Macrociclos de benzotiazole como inibidores da replicação do vírus da imunodeficiência humana
|
US9409922B2
(en)
*
|
2014-02-18 |
2016-08-09 |
Bristol-Myers Squibb Company |
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
|
WO2015126765A1
(en)
|
2014-02-19 |
2015-08-27 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
WO2015127003A1
(en)
|
2014-02-20 |
2015-08-27 |
Bristol-Myers Squibb Company |
Pyridin-3-yl acetic acid macrocycles as inhibitors of human immunodeficiency virus replication
|
US9193720B2
(en)
|
2014-02-20 |
2015-11-24 |
Bristol-Myers Squibb Company |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
US10202353B2
(en)
|
2014-02-28 |
2019-02-12 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
JP6579549B2
(ja)
|
2014-05-16 |
2019-09-25 |
塩野義製薬株式会社 |
Hiv複製阻害作用を有する3環性複素環誘導体
|
TW201625354A
(zh)
|
2014-06-16 |
2016-07-16 |
陶氏農業科學公司 |
用於製備氧硼基化芳烴之方法
|
TW201613936A
(en)
|
2014-06-20 |
2016-04-16 |
Gilead Sciences Inc |
Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
NO2717902T3
(ja)
|
2014-06-20 |
2018-06-23 |
|
|
TW201617331A
(zh)
|
2014-07-08 |
2016-05-16 |
Viiv醫療保健英國有限公司 |
異吲哚啉衍生物
|
AU2015287773B2
(en)
|
2014-07-11 |
2018-03-29 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors for the treatment of HIV
|
EP3172189A1
(en)
*
|
2014-07-21 |
2017-05-31 |
VIIV Healthcare UK Limited |
Phenyl and tertbutylacetic acid substituted pyridinones having anti-hiv effects
|
CN107001357A
(zh)
*
|
2014-08-27 |
2017-08-01 |
Viiv保健英国第五有限公司 |
用作人免疫缺陷病毒复制抑制剂的咪唑并[1,2‑a]吡啶衍生物
|
US20160067255A1
(en)
|
2014-09-04 |
2016-03-10 |
Gilead Sciences, Inc. |
Methods of treating or preventing hiv in patients using a combination of tenofovir alafenamide and dolutegravir
|
CN106715431A
(zh)
|
2014-09-16 |
2017-05-24 |
吉利德科学公司 |
Toll样受体调节剂的固体形式
|
TWI695003B
(zh)
|
2014-12-23 |
2020-06-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
NZ733135A
(en)
|
2014-12-24 |
2018-06-29 |
Gilead Sciences Inc |
Fused pyrimidine compounds for the treatment of hiv
|
TWI699355B
(zh)
|
2014-12-24 |
2020-07-21 |
美商基利科學股份有限公司 |
喹唑啉化合物
|
CN107428693B
(zh)
|
2014-12-24 |
2020-05-29 |
吉利德科学公司 |
用于hiv治疗的异喹啉化合物
|
PL3321265T3
(pl)
|
2015-03-04 |
2020-11-16 |
Gilead Sciences, Inc. |
Związki 4,6-diamino-pirydo[3,2-d]pirymidynowe i ich wykorzystanie jako modulatorów receptorów toll-podobnych
|
EP3466490B1
(en)
|
2015-04-02 |
2020-10-21 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
WO2016194806A1
(ja)
*
|
2015-05-29 |
2016-12-08 |
塩野義製薬株式会社 |
Hiv複製阻害作用を有する含窒素3環性誘導体
|
EP3319958A1
(en)
*
|
2015-07-06 |
2018-05-16 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
US10221156B2
(en)
|
2015-07-08 |
2019-03-05 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
US20180170904A1
(en)
*
|
2015-07-09 |
2018-06-21 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
BR112018000253A2
(pt)
*
|
2015-07-09 |
2018-09-04 |
Viiv Healthcare Uk No 5 Ltd |
composto, composição, e, método para tratar a infecção pelo hiv.
|
CA2994512A1
(en)
|
2015-08-07 |
2017-02-16 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
BR112018002681A2
(pt)
|
2015-08-10 |
2019-04-24 |
Viiv Healthcare Uk No 5 Ltd |
?composto, composição, e, método para tratamento de infecção por hiv?
|
TWI657086B
(zh)
*
|
2015-08-11 |
2019-04-21 |
英商Viiv醫療保健英國(No.5)有限公司 |
做為人類免疫缺陷病毒複製抑制劑之5-(n-苯甲基四氫異喹啉-6-基)吡啶-3-基乙酸衍生物
|
TW201718537A
(zh)
*
|
2015-08-12 |
2017-06-01 |
Viiv醫療保健英國(No.5)有限公司 |
做為人類免疫缺陷病毒複製抑制劑之吡啶-3-基乙酸衍生物
|
EP3334723B1
(en)
*
|
2015-08-12 |
2019-09-18 |
VIIV Healthcare UK (No.5) Limited |
5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
EP3334722A1
(en)
|
2015-08-12 |
2018-06-20 |
VIIV Healthcare UK (No.5) Limited |
5-(n-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3- yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
BR112018003181A2
(pt)
|
2015-08-20 |
2018-09-25 |
Viiv Healthcare Uk No 5 Ltd |
composto, composição, e, método para tratar infecção por hiv
|
JP2018525412A
(ja)
|
2015-08-26 |
2018-09-06 |
ギリアード サイエンシーズ, インコーポレイテッド |
重水素化トール様受容体調節因子
|
CA2997955A1
(en)
|
2015-09-15 |
2017-03-23 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors for the treatment of hiv
|
CA2999516A1
(en)
|
2015-09-30 |
2017-04-06 |
Gilead Sciences, Inc. |
Compounds and combinations for the treatment of hiv
|
US20170107216A1
(en)
*
|
2015-10-19 |
2017-04-20 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
SG10202004618TA
(en)
|
2015-11-19 |
2020-06-29 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
JP2018536001A
(ja)
|
2015-12-04 |
2018-12-06 |
ヴィーブ ヘルスケア ユーケー リミテッド |
イソインドリン誘導体
|
EA202091898A1
(ru)
|
2015-12-15 |
2021-06-22 |
Джилид Сайэнс, Инк. |
Антитела, нейтрализующие вирус иммунодефицита человека
|
SG11201805300QA
(en)
|
2015-12-22 |
2018-07-30 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
EP3452476B1
(en)
|
2016-05-06 |
2021-12-15 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2017195111A1
(en)
|
2016-05-11 |
2017-11-16 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
US20200325127A1
(en)
|
2016-05-11 |
2020-10-15 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
US10407410B2
(en)
|
2016-05-11 |
2019-09-10 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
US20170342060A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
PT3472167T
(pt)
|
2016-06-20 |
2022-11-11 |
Incyte Corp |
Compostos heterocíclicos como imunomoduladores
|
JP7185532B2
(ja)
*
|
2016-06-27 |
2022-12-07 |
ケモセントリックス,インコーポレイティド |
免疫調節化合物
|
AU2017294231B2
(en)
|
2016-07-05 |
2021-09-09 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd |
Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof
|
EP3484866B1
(en)
|
2016-07-14 |
2022-09-07 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
EP4265299A3
(en)
|
2016-08-19 |
2024-01-17 |
Gilead Sciences, Inc. |
Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection
|
US20180057486A1
(en)
|
2016-08-29 |
2018-03-01 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2018042331A1
(en)
|
2016-08-31 |
2018-03-08 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Combinations and uses and treatments thereof
|
WO2018042332A1
(en)
|
2016-08-31 |
2018-03-08 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Combinations and uses and treatments thereof
|
SI3507276T1
(sl)
|
2016-09-02 |
2022-01-31 |
Gilead Sciences, Inc. |
Spojine modulatorja toličnih receptorjev
|
WO2018045150A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
WO2018051250A1
(en)
|
2016-09-14 |
2018-03-22 |
Viiv Healthcare Company |
Combination comprising tenofovir alafenamide, bictegravir and 3tc
|
WO2018064080A1
(en)
|
2016-09-28 |
2018-04-05 |
Gilead Sciences, Inc. |
Benzothiazol-6-yl acetic acid derivatives and their use for treating hiv infection
|
EP3532478B1
(en)
|
2016-10-27 |
2021-05-26 |
Gilead Sciences, Inc. |
Crystalline form of darunavir free base
|
MA47120A
(fr)
|
2016-12-22 |
2021-04-28 |
Incyte Corp |
Dérivés pyridine utilisés en tant qu'immunomodulateurs
|
MY197635A
(en)
|
2016-12-22 |
2023-06-29 |
Incyte Corp |
Benzooxazole derivatives as immunomodulators
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
HUE060233T2
(hu)
|
2016-12-22 |
2023-02-28 |
Incyte Corp |
Tetrahidro imidazo[4,5-c]piridin-származékok mint a PD-L1 internalizációját indukáló szerek
|
EP3565810A1
(en)
|
2017-01-03 |
2019-11-13 |
ViiV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
JP2020503348A
(ja)
|
2017-01-03 |
2020-01-30 |
ヴィーブ ヘルスケア ユーケー(ナンバー5)リミテッド |
ヒト免疫不全ウイルス複製の阻害剤としてのピリジン−3−イル酢酸誘導体
|
AR110768A1
(es)
|
2017-01-31 |
2019-05-02 |
Gilead Sciences Inc |
Formas cristalinas de tenofovir alafenamida
|
JOP20180009A1
(ar)
|
2017-02-06 |
2019-01-30 |
Gilead Sciences Inc |
مركبات مثبط فيروس hiv
|
ES2907099T3
(es)
*
|
2017-06-14 |
2022-04-21 |
Bayer Ag |
Procedimiento de preparación de 3,4-dicloro-N-(2-cianofenil)-5-isotiazol carboxamida
|
CA3065328C
(en)
|
2017-06-21 |
2023-08-15 |
Gilead Sciences, Inc. |
Multispecific antibodies that target hiv gp120 and cd3
|
US10919852B2
(en)
|
2017-07-28 |
2021-02-16 |
Chemocentryx, Inc. |
Immunomodulator compounds
|
EP3960740B1
(en)
|
2017-08-01 |
2023-11-15 |
Gilead Sciences, Inc. |
Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) vanillate for treating viral infections
|
JP7198269B2
(ja)
|
2017-08-08 |
2022-12-28 |
ケモセントリックス,インコーポレイティド |
大員環免疫調節剤
|
TW202024061A
(zh)
|
2017-08-17 |
2020-07-01 |
美商基利科學股份有限公司 |
Hiv蛋白質膜抑制劑之固體形式
|
AR112412A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas de sal de colina de un inhibidor de la cápside del vih
|
AU2018319538B9
(en)
|
2017-08-22 |
2021-05-27 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
JOP20180092A1
(ar)
|
2017-10-13 |
2019-04-13 |
Gilead Sciences Inc |
مثبطات hiv بروتياز
|
EP3700573A1
(en)
|
2017-10-24 |
2020-09-02 |
Gilead Sciences, Inc. |
Methods of treating patients co-infected with a virus and tuberculosis
|
CA3084582A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
EP3728283B1
(en)
|
2017-12-20 |
2023-11-22 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
EP3733659B1
(en)
|
2017-12-29 |
2023-12-20 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd. |
Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
|
JP7068474B2
(ja)
|
2018-01-19 |
2022-05-16 |
ギリアード サイエンシーズ, インコーポレイテッド |
ビクテグラビルの代謝物
|
KR102587510B1
(ko)
|
2018-02-15 |
2023-10-11 |
길리애드 사이언시즈, 인코포레이티드 |
피리딘 유도체 및 hiv 감염을 치료하기 위한 그의 용도
|
JP7038843B2
(ja)
|
2018-02-16 |
2022-03-18 |
ギリアード サイエンシーズ, インコーポレイテッド |
Retroviridaeウイルス感染の処置において有用な治療用化合物を調製するための方法および中間体
|
US10568874B2
(en)
|
2018-02-22 |
2020-02-25 |
Chemocentryx, Inc. |
Indane-amines as PD-L1 antagonists
|
DK3774791T3
(da)
|
2018-03-30 |
2023-01-23 |
Incyte Corp |
Heterocykliske forbindelser som immunmodulatorer
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
2,2,─環二核苷酸
|
KR20200140867A
(ko)
|
2018-04-06 |
2020-12-16 |
인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. |
3'3'-사이클릭 다이뉴클레오티드
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
PT3790877T
(pt)
|
2018-05-11 |
2023-05-10 |
Incyte Corp |
Derivados de tetrahidro-imidazo[4,5-c]piridina como imunomoduladores pd-l1
|
WO2019244066A2
(en)
|
2018-06-19 |
2019-12-26 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
WO2020003093A1
(en)
|
2018-06-25 |
2020-01-02 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
EP3817819A1
(en)
|
2018-07-03 |
2021-05-12 |
Gilead Sciences, Inc. |
Antibodies that target hiv gp120 and methods of use
|
KR102651420B1
(ko)
|
2018-07-06 |
2024-03-28 |
길리애드 사이언시즈, 인코포레이티드 |
치료 헤테로시클릭 화합물
|
US11186579B2
(en)
|
2018-07-06 |
2021-11-30 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
KR20230141905A
(ko)
|
2018-07-16 |
2023-10-10 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv의 치료를 위한 캡시드 억제제
|
TWI766172B
(zh)
|
2018-07-30 |
2022-06-01 |
美商基利科學股份有限公司 |
抗hiv化合物
|
CA3113011A1
(en)
|
2018-09-19 |
2020-03-26 |
Gilead Sciences, Inc. |
Integrase inhibitors for the prevention of hiv
|
WO2020072656A1
(en)
|
2018-10-03 |
2020-04-09 |
Gilead Sciences, Inc. |
Imidozopyrimidine derivatives
|
CN117105933A
(zh)
|
2018-10-31 |
2023-11-24 |
吉利德科学公司 |
具有hpk1抑制活性的取代的6-氮杂苯并咪唑化合物
|
KR102650496B1
(ko)
|
2018-10-31 |
2024-03-26 |
길리애드 사이언시즈, 인코포레이티드 |
Hpk1 억제제로서의 치환된 6-아자벤즈이미다졸 화합물
|
WO2020176505A1
(en)
|
2019-02-25 |
2020-09-03 |
Gilead Sciences, Inc. |
Protein kinase c agonists
|
WO2020176510A1
(en)
|
2019-02-25 |
2020-09-03 |
Gilead Sciences, Inc. |
Protein kinase c agonists
|
JP7350871B2
(ja)
|
2019-03-07 |
2023-09-26 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール,ヴイ.ヴイ.アイ. |
2’3’-環状ジヌクレオチドおよびそのプロドラッグ
|
EP3935066A1
(en)
|
2019-03-07 |
2022-01-12 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
US11766447B2
(en)
|
2019-03-07 |
2023-09-26 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3′3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
WO2020197991A1
(en)
|
2019-03-22 |
2020-10-01 |
Gilead Sciences, Inc. |
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
|
TW202104210A
(zh)
|
2019-04-17 |
2021-02-01 |
美商基利科學股份有限公司 |
Hiv蛋白酶抑制劑
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
WO2020214647A1
(en)
|
2019-04-17 |
2020-10-22 |
Gilead Sciences, Inc. |
Solid forms of an hiv protease inhibitor
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
TW202231277A
(zh)
|
2019-05-21 |
2022-08-16 |
美商基利科學股份有限公司 |
鑑別對使用gp120 v3聚醣導向之抗體的治療敏感之hiv病患的方法
|
WO2020237025A1
(en)
|
2019-05-23 |
2020-11-26 |
Gilead Sciences, Inc. |
Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
|
RU2717101C1
(ru)
|
2019-06-03 |
2020-03-18 |
Андрей Александрович Иващенко |
Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения
|
US20220305115A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
BR112021026376A2
(pt)
|
2019-06-25 |
2022-05-10 |
Gilead Sciences Inc |
Proteínas de fusão flt3l-fc e métodos de uso
|
CA3145303A1
(en)
|
2019-07-10 |
2021-01-14 |
Chemocentryx, Inc. |
Indanes as pd-l1 inhibitors
|
CA3145791A1
(en)
|
2019-07-16 |
2021-01-21 |
Gilead Sciences, Inc. |
Hiv vaccines and methods of making and using
|
US20220257619A1
(en)
|
2019-07-18 |
2022-08-18 |
Gilead Sciences, Inc. |
Long-acting formulations of tenofovir alafenamide
|
WO2021030162A1
(en)
|
2019-08-09 |
2021-02-18 |
Incyte Corporation |
Salts of a pd-1/pd-l1 inhibitor
|
WO2021034804A1
(en)
|
2019-08-19 |
2021-02-25 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
KR20220075382A
(ko)
|
2019-09-30 |
2022-06-08 |
인사이트 코포레이션 |
면역조절제로서의 피리도[3,2-d]피리미딘 화합물
|
AU2020385113A1
(en)
|
2019-11-11 |
2022-05-19 |
Incyte Corporation |
Salts and crystalline forms of a PD-1/PD-L1 inhibitor
|
US11807625B2
(en)
|
2019-11-26 |
2023-11-07 |
Gilead Sciences, Inc. |
Capsid inhibitors for the prevention of HIV
|
AU2020412875A1
(en)
|
2019-12-24 |
2022-06-23 |
Carna Biosciences, Inc. |
Diacylglycerol kinase modulating compounds
|
CR20220418A
(es)
|
2020-02-24 |
2022-10-10 |
Gilead Sciences Inc |
Compuestos tetracíclicos para el tratamiento de infecciones por vih
|
KR20220156884A
(ko)
|
2020-03-20 |
2022-11-28 |
길리애드 사이언시즈, 인코포레이티드 |
4'-c-치환된-2-할로-2'-데옥시아데노신 뉴클레오시드의 프로드러그 및 이의 제조 및 사용 방법
|
WO2021236944A1
(en)
|
2020-05-21 |
2021-11-25 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising bictegravir
|
CA3181690A1
(en)
|
2020-06-25 |
2021-12-30 |
Chienhung CHOU |
Capsid inhibitors for the treatment of hiv
|
AU2021320236A1
(en)
|
2020-08-07 |
2023-04-13 |
Gilead Sciences, Inc. |
Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use
|
AU2021351491A1
(en)
|
2020-09-30 |
2023-05-04 |
Gilead Sciences, Inc. |
Bridged tricyclic carbamoylpyridone compounds and uses thereof
|
TWI815194B
(zh)
|
2020-10-22 |
2023-09-11 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
US11780836B2
(en)
|
2020-11-06 |
2023-10-10 |
Incyte Corporation |
Process of preparing a PD-1/PD-L1 inhibitor
|
US11760756B2
(en)
|
2020-11-06 |
2023-09-19 |
Incyte Corporation |
Crystalline form of a PD-1/PD-L1 inhibitor
|
CR20230230A
(es)
|
2020-11-06 |
2023-07-27 |
Incyte Corp |
Proceso para hacer un inhibidor de pd-1/pdl1 y sales y formas cristalinas del mismo
|
CA3195799A1
(en)
|
2020-11-11 |
2022-05-19 |
Stephen R. Martin |
Methods of identifying hiv patients sensitive to therapy with gp120 cd4 binding site-directed antibodies
|
HUE064467T2
(hu)
|
2021-01-19 |
2024-03-28 |
Gilead Sciences Inc |
Szubsztituált piridotriazin-származékok és alkalmazásuk
|
WO2022245671A1
(en)
|
2021-05-18 |
2022-11-24 |
Gilead Sciences, Inc. |
Methods of using flt3l-fc fusion proteins
|
CN117355531A
(zh)
|
2021-06-23 |
2024-01-05 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
EP4359389A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
EP4359411A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
CN117396478A
(zh)
|
2021-06-23 |
2024-01-12 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
TW202317086A
(zh)
*
|
2021-09-29 |
2023-05-01 |
加拿大商修復治療公司 |
化合物、醫藥組成物及製備化合物之方法及其使用方法
|
AU2022399845A1
(en)
|
2021-12-03 |
2024-05-23 |
Gilead Sciences, Inc. |
Therapeutic compounds for hiv virus infection
|
US20230212148A1
(en)
|
2021-12-03 |
2023-07-06 |
Gilead Sciences, Inc. |
Therapeutic compounds for hiv virus infection
|
CA3235937A1
(en)
|
2021-12-03 |
2023-06-08 |
Gilead Sciences, Inc. |
Therapeutic compounds for hiv virus infection
|
TW202400172A
(zh)
|
2022-04-06 |
2024-01-01 |
美商基利科學股份有限公司 |
橋聯三環胺甲醯基吡啶酮化合物及其用途
|
WO2024006982A1
(en)
|
2022-07-01 |
2024-01-04 |
Gilead Sciences, Inc. |
Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection
|
WO2024015741A1
(en)
|
2022-07-12 |
2024-01-18 |
Gilead Sciences, Inc. |
Hiv immunogenic polypeptides and vaccines and uses thereof
|
US20240083984A1
(en)
|
2022-08-26 |
2024-03-14 |
Gilead Sciences, Inc. |
Dosing and scheduling regimen for broadly neutralizing antibodies
|
WO2024076915A1
(en)
|
2022-10-04 |
2024-04-11 |
Gilead Sciences, Inc. |
4'-thionucleoside analogues and their pharmaceutical use
|